Version 2 2021-07-02, 21:30Version 2 2021-07-02, 21:30
Version 1 2021-06-05, 00:29Version 1 2021-06-05, 00:29
figure
posted on 2021-07-02, 21:30authored byCallie A.S. Corsa, Carolyn M. Walsh, Devika P. Bagchi, Maria C. Foss Freitas, Ziru Li, Julie Hardij, Katrina Granger, Hiroyuki Mori, Rebecca L. Schill, Kenneth T. Lewis, Jessica N. Maung, Ruth D. Azaria, Amy E. Rothberg, Elif A. Oral, Ormond A. MacDougald
Mechanisms by which autosomal recessive
mutations in Lmna cause familial
partial lipodystrophy type 2 (FPLD2) are poorly understood. To investigate
function of lamin A/C in adipose tissues, we created mice with an
adipocyte-specific loss of Lmna (LmnaADKO). Although LmnaADKO mice develop and
maintain adipose tissues in early postnatal life, they show a striking and
progressive loss of white and brown adipose tissues as they approach sexual
maturity. LmnaADKO mice exhibit
a surprisingly mild metabolic dysfunction on a chow diet, but on a high fat
diet they share many characteristics of FPLD2 including hyperglycemia, hepatic
steatosis, hyperinsulinemia, and almost undetectable circulating adiponectin
and leptin. Whereas LmnaADKO
mice have reduced regulated and
constitutive bone marrow adipose tissue with a concomitant increase in cortical
bone, FPLD2 patients have reduced bone mass and bone mineral density compared to
controls. In cell culture models of Lmna
deficiency, mesenchymal
precursors undergo adipogenesis
without impairment, whereas fully-differentiated adipocytes have increased
lipolytic responses to adrenergic stimuli. LmnaADKO mice faithfully reproduce many characteristics of
FPLD2 and thus provide a unique animal model to investigate mechanisms
underlying Lmna-dependent loss of
adipose tissues.
Funding
This work was supported by funds from the National Institute of Health to CASC (T32 DK101357), DPB (T32 HD007505 and T32 GM007863), CMW (T32 DK071212), RLS (T32 DK101357 and F32 DK123887), KTL (T32 DK071212 and F32 DK122654), EO (R01 DK125513) and OAM (R24 DK092759, R01 DK125513, R01 DK121759). This work was also supported by postdoctoral fellowships from the American Diabetes Association to CASC (1-18-PDF-064) and ZL (1-18-PDF-087) and from the Michigan Life Sciences Fellows program to CMW. This research was supported by the Michigan Mouse Metabolic Phenotyping Center (U2C DK110768), the Microscopy, Imaging, and Cellular Physiology Core (P30 DK020572), the Adipose Tissue Core of the MNORC (P30 DK089503), and the University of Michigan Advanced Genomics Core. Histological analyses were supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (P30 AR069620).